SuperworthUnicycive Therapeutics shares outstanding UNCY
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 26.9M
- On a year earlier
- +118.8%
- more shares
Unicycive Therapeutics had 26.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 118.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 21.4M | +103% |
| FY2024 | 10.5M | +203% |
| FY2023 | 3.5M | +130% |
| FY2022 | 1.5M | +0% |
| FY2021 | 1.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 26.9M | +119% | |
| Q1 FY26 | 23.9M | +93% | |
| Q4 FY25 | 21.4M | +103% | |
| Q3 FY25 | 18.1M | +103% | |
| Q2 FY25 | 12.3M | +31% | |
| Q1 FY25 | 12.4M | +255% | |
| Q4 FY24 | 10.5M | +203% | |
| Q3 FY24 | 8.9M | +173% | |
| Q2 FY24 | 9.4M | +517% | |
| Q1 FY24 | 3.5M | +129% | |
| Q4 FY23 | 3.5M | +130% | |
| Q3 FY23 | 3.3M | +117% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Unicycive Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.